Screener
Summit Therapeutics SMMT Common Stock Par Value Per Share
Common Stock Par Value Per Share at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The source filing: Summit Therapeutics’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001599298-26-000039
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Commitments and contingencies (Note 12) | ||
| Stockholders' equity: | ||
| Preferred stock, $0.01 par value, 20,000,000 shares authorized; none issued and outstanding at March 31, 2026 and December 31, 2025, respectively | — | — |
| Common stock, $0.01 par value: 1,000,000,000 shares authorized; 776,017,474 and 775,371,200 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 7,760 | 7,754 |
| Additional paid-in capital | 3,024,387 | 2,947,805 |
| Accumulated other comprehensive loss | (2,632) | (2,540) |
| Accumulated deficit | (2,483,583) | (2,294,159) |
| Total stockholders' equity | 545,932 | 658,860 |
Item 1. Financial Statements.
FAQ
- What is Summit Therapeutics's common stock par value per share?
- Summit Therapeutics (SMMT) reported common stock par value per share of $0.01 in Q1 2026.
- How has Summit Therapeutics's common stock par value per share changed year-over-year?
- Summit Therapeutics's common stock par value per share decreased by 0.0% year-over-year, from $0.01 to $0.01.
- What is the long-term trend for Summit Therapeutics's common stock par value per share?
- Over 5 years (2020 to 2025), Summit Therapeutics's common stock par value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0.01 to $0.01.
- What does common stock par value per share mean?
- The par value of common stock is the arbitrary legal value assigned to each share of common stock at the time of issuance. It is a legacy accounting requirement that has little impact on the actual market value or trading price of the shares.
Ask your AI about Summit Therapeutics's common stock par value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude